Clinical Trials

New Search
Title   Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Disease/Condition   Blood and Bone Marrow Cancer,Pediatric Hematology/Oncology,Leukemia,Lymphoma,Lymphatic and Spleen Diseases,Neoplasms,Lymphoproliferative Disorders,Immune System Diseases

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Lisa Gennarini, MD
Contact Name   Annette Pedro
Contact Email
Protocol Number   2015-4852
Inclusion/Notes   This information was obtained from
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   Yes
Sub-Specialty   Acute Lymphoblastic Leukemia (ALL)
Adult, Pediatric, Both   Both